File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward

TitleSerology for SARS-CoV-2: Apprehensions, opportunities, and the path forward
Authors
Bryant, JEAzman, ASFerrari, MJArnold, BFBoni, MFBoum, YHayford, KLuquero, FJMina, MJRodriguez-Barraquer, IWu, JTWade, DVernet, GLeung, DT
KeywordsBetacoronavirus
Coronavirus infection
epidemiological monitoring
human
immunology
Issue Date2020
PublisherAmerican Association for the Advancement of Science. The Journal's web site is located at http://immunology.sciencemag.org/
Citation
Science Immunology, 2020, v. 5 n. 47, p. article no. eabc6347 How to Cite?
DOI: http://dx.doi.org/10.1126/sciimmunol.abc6347
AbstractSerological testing for SARS-CoV-2 has enormous potential to contribute to COVID-19 pandemic response efforts. However, the required performance characteristics of antibody tests will critically depend on the use case (individual level versus population level).
Persistent Identifierhttp://hdl.handle.net/10722/283671
ISSN
2470-9468
2021 Impact Factor: 30.630
2020 SCImago Journal Rankings: 8.830
ISI Accession Number ID
WOS:000546992600008

 

DC FieldValueLanguage
dc.contributor.authorBryant, JE-
dc.contributor.authorAzman, AS-
dc.contributor.authorFerrari, MJ-
dc.contributor.authorArnold, BF-
dc.contributor.authorBoni, MF-
dc.contributor.authorBoum, Y-
dc.contributor.authorHayford, K-
dc.contributor.authorLuquero, FJ-
dc.contributor.authorMina, MJ-
dc.contributor.authorRodriguez-Barraquer, I-
dc.contributor.authorWu, JT-
dc.contributor.authorWade, D-
dc.contributor.authorVernet, G-
dc.contributor.authorLeung, DT-
dc.date.accessioned2020-07-03T08:22:28Z-
dc.date.available2020-07-03T08:22:28Z-
dc.date.issued2020-
dc.identifier.citationScience Immunology, 2020, v. 5 n. 47, p. article no. eabc6347-
dc.identifier.issn2470-9468-
dc.identifier.urihttp://hdl.handle.net/10722/283671-
dc.description.abstractSerological testing for SARS-CoV-2 has enormous potential to contribute to COVID-19 pandemic response efforts. However, the required performance characteristics of antibody tests will critically depend on the use case (individual level versus population level).-
dc.languageeng-
dc.publisherAmerican Association for the Advancement of Science. The Journal's web site is located at http://immunology.sciencemag.org/-
dc.relation.ispartofScience Immunology-
dc.rightsScience Immunology. Copyright © American Association for the Advancement of Science.-
dc.rightsThis is the author’s version of the work. It is posted here by permission of the AAAS for personal use, not for redistribution. The definitive version was published in Science Immunology on v. 5 n. 47, 19 May 2020.DOI: 10.1126/sciimmunol.abc6347-
dc.subjectBetacoronavirus-
dc.subjectCoronavirus infection-
dc.subjectepidemiological monitoring-
dc.subjecthuman-
dc.subjectimmunology-
dc.titleSerology for SARS-CoV-2: Apprehensions, opportunities, and the path forward-
dc.typeArticle-
dc.identifier.emailWu, JT: joewu@hku.hk-
dc.identifier.authorityWu, JT=rp00517-
dc.description.naturepostprint-
dc.identifier.doi10.1126/sciimmunol.abc6347-
dc.identifier.pmid32430309-
dc.identifier.scopuseid_2-s2.0-85084963531-
dc.identifier.hkuros310699-
dc.identifier.volume5-
dc.identifier.issue47-
dc.identifier.spagearticle no. eabc6347-
dc.identifier.epagearticle no. eabc6347-
dc.identifier.isiWOS:000546992600008-
dc.publisher.placeUnited States-
dc.identifier.issnl2470-9468-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats